17 pending office actions • 13 art units • 17 examiners • 0 of 17 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (12%) |
| §103 only | 4 (24%) |
| §102 only | 1 (6%) |
| Double-patenting + other | 1 (6%) |
| Multi-statute (no §101) | 9 (53%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, LEI | 1 | 16.7% | +100.0% |
| AGUDELO, PAOLA | 1 | 77.0% | +16.8% |
| CABRAL, ROBERT S | 1 | 62.6% | +32.4% |
| REILLY, SOPHIA JANE | 1 | 60.6% | +49.1% |
| GAMBETTA, KELLY M | 1 | 71.9% | +33.0% |
| HAN, SETH | 1 | 59.1% | +27.1% |
| MACH, ANDRE | 1 | 45.9% | +53.2% |
| MCCLURE, CHRISTINA D | 1 | 29.9% | +32.9% |
| BROWN, MADISON ELIZABETH | 1 | — | — |
| WASHVILLE, JEFFREY D | 1 | 79.8% | -4.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18144382 | IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA | SHOMER, ISAAC | 91d overdue |
| 17862825 | METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR | CHANDRA, GYAN | 44d overdue |
| 18690227 | VENTRICULAR CATHETERS AND OTHER EMBODIMENTS | HAN, SETH | 24d overdue |
| 18100800 | MOLYBDENUM-DAD PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS | TUROCY, DAVID P | 8d |
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 69d |
| 18252416 | COMPOSITIONS AND METHODS FOR INHIBITION OF TISSUE ADHESION | WASHVILLE, JEFFREY D | 84d |
| 18805953 | HIGH CAPACITY HYBRID FRAME-WALL INTENDED FOR COLD-FORMED STEEL CONSTRUCTION | AGUDELO, PAOLA | — |
| 18742267 | COMPOSITIONS AND METHODS RELATING TO USE OF PHOSPHATIDIC ACID TO RESCUE FETAL ALCOHOL SPECTRUM DISORDER (FASD) GROWTH RESTRICTION AND BLOOD VESSEL CONSTRICTION | REILLY, SOPHIA JANE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690227 | VENTRICULAR CATHETERS AND OTHER EMBODIMENTS | HAN, SETH | 24d overdue |
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 69d |
| 18805953 | HIGH CAPACITY HYBRID FRAME-WALL INTENDED FOR COLD-FORMED STEEL CONSTRUCTION | AGUDELO, PAOLA | — |
| 18780262 | METHOD OF TREATMENT FOR SOLID TUMORS CONTAINING HYPOXIA AND/OR STROMA FEATURES | CABRAL, ROBERT S | — |
| 18742267 | COMPOSITIONS AND METHODS RELATING TO USE OF PHOSPHATIDIC ACID TO RESCUE FETAL ALCOHOL SPECTRUM DISORDER (FASD) GROWTH RESTRICTION AND BLOOD VESSEL CONSTRICTION | REILLY, SOPHIA JANE | — |
| 18601338 | INHERENTLY SELECTIVE THERMAL ATOMIC LAYER DEPOSITION OF COPPER METAL FILMS | GAMBETTA, KELLY M | — |
| 18690241 | METHODS AND COMPOSITIONS TO REDUCE CELLULAR DEPOSITION, AND HYDROCEPHALUS SHUNT FAILURE | MACH, ANDRE | — |
| 18438175 | ATOMIC LAYER DEPOSITION OF GROUP FIFTEEN MATERIALS | MCCLURE, CHRISTINA D | — |
| Art Unit | Apps |
|---|---|
| 1718 | 3 |
| 3798 | 1 |
| 3633 | 1 |
| 3781 | 1 |
| 1615 | 1 |
| 1787 | 1 |
| 1766 | 1 |
| 1612 | 1 |
| 3797 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18858953 | METHOD AND APPARATUS FOR MAGNETIC RESONANCE (MR) CONTRAST AGENTS | ZHANG, LEI | 3798 | §103 | Final Rejection | 69d | Pending | Oct 22, 2024 |
| 18805953 | HIGH CAPACITY HYBRID FRAME-WALL INTENDED FOR COLD-FORMED STEEL CONSTRUCTION | AGUDELO, PAOLA | 3633 | §103§112 | Non-Final OA | — | Pending | Aug 15, 2024 |
| 18780262 | METHOD OF TREATMENT FOR SOLID TUMORS CONTAINING HYPOXIA AND/OR STROMA FEATURES | CABRAL, ROBERT S | — | §112DP | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18742267 | COMPOSITIONS AND METHODS RELATING TO USE OF PHOSPHATIDIC ACID TO RESCUE FETAL ALCOHOL SPECTRUM DISORDER (FASD) GROWTH RESTRICTION AND BLOOD VESSEL CONSTRICTION | REILLY, SOPHIA JANE | — | §101§102§103 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18601338 | INHERENTLY SELECTIVE THERMAL ATOMIC LAYER DEPOSITION OF COPPER METAL FILMS | GAMBETTA, KELLY M | 1718 | §102§103 | Final Rejection | — | Pending | Mar 11, 2024 |
| 18690227 | VENTRICULAR CATHETERS AND OTHER EMBODIMENTS | HAN, SETH | 3781 | §102§103§112 | Final Rejection | 24d overdue | Pending | Mar 07, 2024 |
| 18690241 | METHODS AND COMPOSITIONS TO REDUCE CELLULAR DEPOSITION, AND HYDROCEPHALUS SHUNT FAILURE | MACH, ANDRE | 1615 | §102§103 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18438175 | ATOMIC LAYER DEPOSITION OF GROUP FIFTEEN MATERIALS | MCCLURE, CHRISTINA D | 1718 | §103 | Final Rejection | — | Pending | Feb 09, 2024 |
| 18238648 | HIGH TEMPERATURE LITHIUM-ION BATTERY AND METHOD OF MAKING SAME | BROWN, MADISON ELIZABETH | 1787 | §102§103§112 | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18252416 | COMPOSITIONS AND METHODS FOR INHIBITION OF TISSUE ADHESION | WASHVILLE, JEFFREY D | 1766 | §103§112 | Non-Final OA | 84d | Pending | May 10, 2023 |
| 18144382 | IN VIVO IMMUNOIMAGING OF INTERFERON-GAMMA | SHOMER, ISAAC | 1612 | §102§103§112 | Final Rejection | 91d overdue | Pending | May 08, 2023 |
| 18028150 | SYSTEMS AND METHODS FOR PREDICTING AND PREVENTING BLEEDING AND OTHER ADVERSE EVENTS | COOK, CHRISTOPHER L | 3797 | §103 | Final Rejection | 53d | Pending | Mar 23, 2023 |
| 18100800 | MOLYBDENUM-DAD PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS | TUROCY, DAVID P | 1718 | §103§112 | Final Rejection | 8d | Pending | Jan 24, 2023 |
| 18045126 | DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS | MARTIN, PAUL C | 1653 | §102 | Final Rejection | 91d overdue | Pending | Oct 07, 2022 |
| 17930042 | AMPHIPHILIC OLIGODEOXYNUCLEOTIDE CONJUGATES AS ADJUVANT ENHANCERS | CHONG, KIMBERLY | 1636 | §102§103§112 | Final Rejection | — | Pending | Sep 06, 2022 |
| 17862825 | METHODS AND COMPOSITIONS RELATING TO HOT-START, ONE-STEP, REVERSE TRANSCRIPTION-COUPLED PCR | CHANDRA, GYAN | 1674 | §101§103 | Final Rejection | 44d overdue | Pending | Jul 12, 2022 |
| 16826010 | ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME | RYAN, DOUGLAS CHARLES | 1635 | §103 | Non-Final OA | — | Pending | Mar 20, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial